Please enable Javascript to use all features and improve your user experience.
EHC 2024
Programme
Posters
Search
EN
Poster
P047
ePoster
Design of an enriched randomized withdrawal, placebo-controlled phase 2/3 trial of basimglurant, a mGluR5 NAM, first-in-disease approach to treat pain associated with Trigeminal Neuralgia (LIBRA Study)
Presented in
ePoster 04
Poster topics
Trigeminal neuralgia
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy